EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanopore sequencing of infectious fluid is a promising supplement for gold-standard culture in real-world clinical scenario

Manna Zhao, Yongyang Zhang, Li Chen, Xuebing Yan, Tianmin Xu, Maoying Fu, Yangguang Han, Ying Zhang, Bin Zhang, Juan Cao, Jing Lin, Dan Shen und 3 weitere

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1330788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Manna Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Nanopore Sequencing, Mycobacterium tuberculosis, Communicable Diseases, Staphylococcal Infections. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Infectious diseases are major causes of morbidity and mortality worldwide, necessitating the rapid identification and accurate diagnosis of pathogens. While unbiased metagenomic next-generation sequencing (mNGS) has been extensively utilized in clinical pathogen identification and scientific microbiome detection, there is limited research about the application of nanopore platform-based mNGS in the diagnostic performance of various infectious fluid samples.

Methods

In this study, we collected 297 suspected infectious fluids from 10 clinical centers and detected them with conventional microbiology culture and nanopore platform–based mNGS. The objective was to assess detective and diagnostic performance of nanopore-sequencing technology (NST) in real-world scenarios.

Results

Combined with gold-standard culture and clinical adjudication, nanopore sequencing demonstrated nearly 100% positive predictive agreements in microbial-colonized sites, such as the respiratory and urinary tracts. For samples collected from initially sterile body sites, the detected microorganisms were highly suspected pathogens, and the negative predictive agreements were relatively higher than those in the microbial-colonized sites, particularly with 100% in abscess and 95.7% in cerebrospinal fluid. Furthermore, consistent performance was also observed in the identification of antimicrobial resistance genes and drug susceptibility testing of pathogenic strains of Escherichia coli , Staphylococcus aureus , and Acinetobacter baumannii .

Discussion

Rapid NST is a promising clinical tool to supplement gold-standard culture, and it has the potential improve patient prognosis and facilitate clinical treatment of infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nanopore SequencingMycobacterium tuberculosisCommunicable DiseasesStaphylococcal InfectionsHumansMicrobial Sensitivity TestsEscherichia coliHigh-Throughput Nucleotide SequencingMetagenomicsSensitivity and Specificity

Stichwörter der Autor:innen

diagnosisinfectious body fluidsinfectious diseasesmetagenomic next-generation sequencing (mNGS)nanopore sequencing technology (NST)

Autor:innen und Institutionen

  • Department of Infectious Diseases, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Department of Infectious Diseases, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
  • Department of Infectious Disease, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
  • Department of Infectious Diseases, The Third People's Hospital of Changzhou, Changzhou, Jiangsu, China.
  • Infectious Diseases Department, Kunshan First People's Hospital, Kunshan, Jiangsu, China.
  • Department of Infectious Diseases, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.

Zitieren

APA

Zhao, M., Zhang, Y., Chen, L., Yan, X., Xu, T., Fu, M., Han, Y., Zhang, Y., Zhang, B., Cao, J., Lin, J., Shen, D., Li, S., Zhu, C., & Zhao, W. (2024). Nanopore sequencing of infectious fluid is a promising supplement for gold-standard culture in real-world clinical scenario. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1330788

Vancouver

Zhao M, Zhang Y, Chen L, Yan X, Xu T, Fu M, et al. Nanopore sequencing of infectious fluid is a promising supplement for gold-standard culture in real-world clinical scenario. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1330788

BibTeX
@article{Zhao2024,
  author = {Zhao, Manna and Zhang, Yongyang and Chen, Li and Yan, Xuebing and Xu, Tianmin and Fu, Maoying and Han, Yangguang and Zhang, Ying and Zhang, Bin and Cao, Juan and Lin, Jing and Shen, Dan and Li, Shuo and Zhu, Chuanlong and Zhao, Weifeng},
  title = {Nanopore sequencing of infectious fluid is a promising supplement for gold-standard culture in real-world clinical scenario},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1330788}
}
Kostenlos starten →